Formulation of Silver Nanoparticles using Gymnema sylvestre Leaf Extract and In-vitro Anti-diabetic Activity
Ajinkya B. Chavan, Swapnil Goyal, Ansar M. Patel
Journal of Pharmaceutical Research International · pp. 39–49 · Published 30 Jan 2022
10.9734/jpri/2022/v34i7A35450Abstract
Aim: Formulation of Silver Nanoparticles Using Gymnema sylvestre Leaf Extract and In-Vitro Anti-diabetic Activity. Place and Duration of the Study: The present work has been carried out between April-2021 to July-2021 and at Mandasur University Mandsaur, Madhya Pradesh-458001. Methodology: A versatile technique was implemented for the synthesis of silver nanoparticles using aqueous and alcoholic extract of leaves of Gymnema sylvestre. The Ag-NP was subjected to UV, FTIR, XRD, and particle size analysis. The silver nanoparticles Gymnema sylvestre evaluated its anti-diabetic activity by inhibiting the enzymes α-amylase. Results: The reduction of silver nitrate to silver nanoparticles was confirmed by UV-Vis spectrophotometer showing a typical resonance (SPR) at about 400 nm which is specific for Ag-NPs. In FT-IR analysis the strong band peak at 3355 cm-1 in the extract is vibration bands, which may be due to the overlapping of amine N-H stretching bands. SEM and EDX images reveal that the particles are spherical and the relatively uniform shape of the silver nanoparticles was confirmed in the range of 70-100 nm in extract, whereas DLS showed good zeta potential and less particle size. Conclusions: The silver nanoparticles that were biologically synthesized from Gymnema sylvestre were economical, non-toxic, and environmentally benign. Due to the reducing and capping nature of the bioactive Phyto-compounds, present in the aqueous extracts. This extract is found to be suitable for the green synthesis of silver nanoparticles. Synthesized silver nanoparticles exhibit the highest level of anti-diabetic activity by inhibiting carbohydrate metabolizing enzymes such as α-amylase. Therefore, synthesized nanoparticles can be a good therapeutic agent for controlling diabetes by inhibiting enzymes that hydrolyze carbohydrates.
Cited by 12
Jameel M Al-Khayri, Wudali N. Sudheer, Akshatha Banadka · Applied Microbiology and Biotechnology · 2023
Mst. Sanjida Akhter, Md. Ataur Rahman, Rezaul Karim Ripon · Heliyon · 2024
Ahmad Almatroudi · Pharmaceutics · 2024
Showing 3 of 12 known citations — external sources report more than can currently be individually listed.
Related research
- α-Amylase Production on Low-Cost Substrates by Naxibacter sp. Isolated from Mauritian Soils — shares topic coverage
- Production of Halophilic α-Amylase by Immobilized Cells of Moderately Halophilic Bacillus sp. Strain TSCVKK — shares topic coverage
- An Insight into the Precise Molecular Interaction and Inhibitory Potential of Amentoflavone and Its Substituted Derivatives on Human α-amylase — shares topic coverage
- Biochemical Changes in Tissues of Telfaria occidentalis Leaves Following Subchronic Exposure to some Heavy Metals — shares topic coverage
- In vitro and In vivo Assessment of the Anti-diabetes Potentials of Murraya koenigii, Hibiscus cannabinus, Vernonia amydalina and Telfairia occidentalis Leave Extract — shares topic coverage
Article metrics
Real usage data collected on this platform.
4
Page views
0
PDF downloads
0
Outbound clicks
12
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.